Facial Injectables Market Research Report by Type (Anti-aging Injections and Dermal Fillers), by End User (Beauty Clinics, Dermatology Clinics, and Dermatology Research Institutes), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) -

Facial Injectables Market Research Report by Type (Anti-aging Injections and Dermal Fillers), by End User (Beauty Clinics, Dermatology Clinics, and Dermatology Research Institutes), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

The Global Facial Injectables Market size was estimated at USD 10.41 Billion in 2020 and expected to reach USD 11.56 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 11.44% from 2020 to 2026 to reach USD 19.95 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Facial Injectables to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the Facial Injectables Market was studied across Anti-aging Injections and Dermal Fillers. The Anti-aging Injections is further studied across Botulinum Toxin A and Poly-L-Lactic Acid (PLLA) Micro Particles. The Dermal Fillers is further studied across Collagen Fillers, Hyaluronic Acid, and Synthetic Fillers.

Based on End User, the Facial Injectables Market was studied across Beauty Clinics, Dermatology Clinics, Dermatology Research Institutes, and Hospitals.

Based on Geography, the Facial Injectables Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Facial Injectables Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Facial Injectables Market, including Advanced Dermatology, Allergan, Plc, Anika Therapeutics, Inc., Antares Pharma, AstraZeneca, Becton, Dickinson and Company, Bloomage BioTechnology Corporation Limited, ColBar LifeScience Ltd., Eisai Co. Ltd, Eli Lilly and Company,, F. Hoffmann-La Roche AG,, Galderma Laboratories, L.P., Inovio Pharmaceuticals Inc., Ipse, Johnson and Johnson Services Inc., Medytox, Inc., Merz, Inc., Mylan N. V., Novartis AG, Novo Nordisk, Pfizer Inc, Prollenium Medical Technologies Inc., Sanofi, Sanofi Biosurgery Inc., Sinclair Pharma, Suneva Medical, Inc., Teva Pharmaceutical Industries Ltd, and Valeant Pharmaceuticals North America LLC..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Facial Injectables Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Facial Injectables Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Facial Injectables Market?
4. What is the competitive strategic window for opportunities in the Global Facial Injectables Market?
5. What are the technology trends and regulatory frameworks in the Global Facial Injectables Market?
6. What is the market share of the leading vendors in the Global Facial Injectables Market?
7. What modes and strategic moves are considered suitable for entering the Global Facial Injectables Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. End User Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing focus on physical appearance among consumers globally
5.1.1.2. Rising penchant toward minimally invasive procedures among people
5.1.1.3. Growing disposable income among people and availability of numerous treatment options
5.1.2. Restraints
5.1.2.1. Relatively high costs of the fillers
5.1.3. Opportunities
5.1.3.1. Introduction of advanced treatment options
5.1.3.2. Rising adoption of self-injectable devices and the growing geriatric population
5.1.4. Challenges
5.1.4.1. Strict regulatory concerns and probable side effects such as rashes
5.2. Cumulative Impact of COVID-19
5.3. Porters Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
6. Facial Injectables Market, by Type
6.1. Introduction
6.2. Anti-aging Injections
6.2.1. Botulinum Toxin A
6.2.2. Poly-L-Lactic Acid (PLLA) Micro Particles
6.3. Dermal Fillers
6.3.1. Collagen Fillers
6.3.2. Hyaluronic Acid
6.3.3. Synthetic Fillers
7. Facial Injectables Market, by End User
7.1. Introduction
7.2. Beauty Clinics
7.3. Dermatology Clinics
7.4. Dermatology Research Institutes
7.5. Hospitals
8. Americas Facial Injectables Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
8.6.1. California
8.6.2. Florida
8.6.3. Illinois
8.6.4. New York
8.6.5. Ohio
8.6.6. Pennsylvania
8.6.7. Texas
9. Asia-Pacific Facial Injectables Market
9.1. Introduction
9.2. China
9.3. India
9.4. Indonesia
9.5. Japan
9.6. Malaysia
9.7. Philippines
9.8. South Korea
9.9. Thailand
10. Europe, Middle East & Africa Facial Injectables Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Advanced Dermatology
12.2. Allergan, Plc
12.3. Anika Therapeutics, Inc.
12.4. Antares Pharma
12.5. AstraZeneca
12.6. Becton, Dickinson and Company
12.7. Bloomage BioTechnology Corporation Limited
12.8. ColBar LifeScience Ltd.
12.9. Eisai Co. Ltd
12.10. Eli Lilly and Company,
12.11. F. Hoffmann-La Roche AG,
12.12. Galderma Laboratories, L.P.
12.13. Inovio Pharmaceuticals Inc.
12.14. Ipse
12.15. Johnson and Johnson Services Inc.
12.16. Medytox, Inc.
12.17. Merz, Inc.
12.18. Mylan N. V.
12.19. Novartis AG
12.20. Novo Nordisk
12.21. Pfizer Inc
12.22. Prollenium Medical Technologies Inc.
12.23. Sanofi
12.24. Sanofi Biosurgery Inc.
12.25. Sinclair Pharma
12.26. Suneva Medical, Inc.
12.27. Teva Pharmaceutical Industries Ltd
12.28. Valeant Pharmaceuticals North America LLC.
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
13.3. Contact Details
List of Figures
FIGURE 1. GLOBAL FACIAL INJECTABLES MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2020 (USD BILLION)
FIGURE 3. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2020 (USD BILLION)
FIGURE 4. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
FIGURE 5. GLOBAL FACIAL INJECTABLES MARKET: MARKET DYNAMICS
FIGURE 6. GLOBAL FACIAL INJECTABLES MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 7. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 8. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2020 VS 2026 (USD BILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2026
FIGURE 10. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2026 (USD BILLION)
FIGURE 11. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 12. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2026 (USD BILLION)
FIGURE 13. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN A, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 14. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES, 2018-2026 (USD BILLION)
FIGURE 15. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 16. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2026 (USD BILLION)
FIGURE 17. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 18. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY COLLAGEN FILLERS, 2018-2026 (USD BILLION)
FIGURE 19. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY COLLAGEN FILLERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 20. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HYALURONIC ACID, 2018-2026 (USD BILLION)
FIGURE 21. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HYALURONIC ACID, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 22. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY SYNTHETIC FILLERS, 2018-2026 (USD BILLION)
FIGURE 23. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY SYNTHETIC FILLERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 24. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 25. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2020 VS 2026 (USD BILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2026
FIGURE 27. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BEAUTY CLINICS, 2018-2026 (USD BILLION)
FIGURE 28. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BEAUTY CLINICS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 29. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2026 (USD BILLION)
FIGURE 30. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 31. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY RESEARCH INSTITUTES, 2018-2026 (USD BILLION)
FIGURE 32. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY RESEARCH INSTITUTES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 33. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HOSPITALS, 2018-2026 (USD BILLION)
FIGURE 34. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 35. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 36. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 38. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 39. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 40. CANADA FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 41. MEXICO FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 42. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 43. CALIFORNIA FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 44. FLORIDA FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 45. ILLINOIS FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 46. NEW YORK FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 47. OHIO FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 48. PENNSYLVANIA FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 49. TEXAS FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 50. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 51. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 53. CHINA FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 54. INDIA FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 55. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 56. JAPAN FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 57. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 58. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 59. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 60. THAILAND FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 62. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 64. FRANCE FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 65. GERMANY FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 66. ITALY FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 67. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 68. QATAR FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 69. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 70. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 71. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 72. SPAIN FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 73. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 74. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
FIGURE 75. GLOBAL FACIAL INJECTABLES MARKET: FPNV POSITIONING MATRIX
FIGURE 76. GLOBAL FACIAL INJECTABLES MARKET: MARKET SHARE ANALYSIS, BY QUADRANT
FIGURE 77. GLOBAL FACIAL INJECTABLES MARKET: MARKET SHARE ANALYSIS, BY COMPANY
FIGURE 78. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL FACIAL INJECTABLES MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL FACIAL INJECTABLES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 4. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 5. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN A, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 6. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 7. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 8. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY COLLAGEN FILLERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 9. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HYALURONIC ACID, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 10. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY SYNTHETIC FILLERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 11. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 12. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BEAUTY CLINICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 13. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 14. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY RESEARCH INSTITUTES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 15. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 16. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 17. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 18. AMERICAS FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 19. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 20. ARGENTINA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 21. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 22. BRAZIL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 23. CANADA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 24. CANADA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 25. MEXICO FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 26. MEXICO FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 27. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 28. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 29. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 30. CALIFORNIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 31. CALIFORNIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 32. FLORIDA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 33. FLORIDA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 34. ILLINOIS FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 35. ILLINOIS FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 36. NEW YORK FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 37. NEW YORK FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 38. OHIO FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 39. OHIO FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 40. PENNSYLVANIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 41. PENNSYLVANIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 42. TEXAS FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 43. TEXAS FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 44. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 45. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 46. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 47. CHINA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 48. CHINA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 49. INDIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 50. INDIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 51. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 52. INDONESIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 53. JAPAN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 54. JAPAN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 55. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 56. MALAYSIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 57. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 58. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 59. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 60. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 61. THAILAND FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 62. THAILAND FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 66. FRANCE FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 67. FRANCE FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 68. GERMANY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 69. GERMANY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 70. ITALY FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 71. ITALY FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 72. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 73. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 74. QATAR FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 75. QATAR FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 76. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 77. RUSSIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 78. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 79. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 80. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 81. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 82. SPAIN FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 83. SPAIN FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 84. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 85. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 86. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 87. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
TABLE 88. GLOBAL FACIAL INJECTABLES MARKET: SCORES
TABLE 89. GLOBAL FACIAL INJECTABLES MARKET: BUSINESS STRATEGY
TABLE 90. GLOBAL FACIAL INJECTABLES MARKET: PRODUCT SATISFACTION
TABLE 91. GLOBAL FACIAL INJECTABLES MARKET: RANKING
TABLE 92. GLOBAL FACIAL INJECTABLES MARKET: MERGER & ACQUISITION
TABLE 93. GLOBAL FACIAL INJECTABLES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 94. GLOBAL FACIAL INJECTABLES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 95. GLOBAL FACIAL INJECTABLES MARKET: INVESTMENT & FUNDING
TABLE 96. GLOBAL FACIAL INJECTABLES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 97. GLOBAL FACIAL INJECTABLES MARKET: LICENSE & PRICING
TABLE 98. GLOBAL FACIAL INJECTABLES MARKET: CONTACT DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook